{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:11:19Z","timestamp":1793257879631,"version":"4.5.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T00:00:00Z","timestamp":1494547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1023239"],"award-info":[{"award-number":["1023239"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1042907"],"award-info":[{"award-number":["1042907"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0177615","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T13:29:05Z","timestamp":1494595745000},"page":"e0177615","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Measurement of tissue azithromycin levels in self-collected vaginal swabs post treatment using liquid chromatography and tandem mass spectrometry (LC-MS\/MS)"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3679-9195","authenticated-orcid":true,"given":"Lenka A.","family":"Vodstrcil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thusitha W. T.","family":"Rupasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian Y. S.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dedreia","family":"Tull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Worthington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelmina M.","family":"Huston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Timms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm J.","family":"McConville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K.","family":"Fairley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona S.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr N.","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane S.","family":"Hocking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,5,12]]},"reference":[{"key":"ref1","unstructured":"Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2014. U.S Department of Health and Human Services 2014. Available from: http:\/\/www.cdc.gov\/std\/stats14\/default.htm<\/ext-link>."},{"issue":"Suppl 2","key":"ref2","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1086\/652395","article-title":"Risk of sequelae after Chlamydia trachomatis genital infection in women","volume":"201","author":"CL Haggerty","year":"2010","journal-title":"The Journal of Infectious Diseases"},{"issue":"25","key":"ref3","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMcp030542","article-title":"Genital Chlamydial Infections","volume":"349","author":"JF Peipert","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"ref4","first-page":"555","article-title":"Sexually Transmitted Diseases","author":"J Schachter","year":"2008"},{"issue":"RR-03","key":"ref5","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"KA Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"ref6","article-title":"2015 European guideline on the management of Chlamydia trachomatis infections","author":"E Lanjouw","year":"2015","journal-title":"Int J STD AIDS"},{"key":"ref7","unstructured":"Alliance ASH. Australian STI management guidelines for use in primary care [cited Last Updated: Monday, 30 November 2015]. Available from: http:\/\/www.sti.guidelines.org.au\/sexually-transmissible-infections\/chlamydia#management<\/ext-link>."},{"key":"ref8","unstructured":"Pfizer. Zithromax product information. Australia2007."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/25.suppl_A.73","article-title":"The pharmacokinetics of azithromycin in human serum and tissues","volume":"25","author":"G Foulds","year":"1990","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1097\/OLQ.0b013e318227a366","article-title":"Questioning azithromycin for chlamydial infection","volume":"38","author":"HH Handsfield","year":"2011","journal-title":"Sex Transm Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/sti.2005.019158","article-title":"The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection","volume":"82","author":"P Horner","year":"2006","journal-title":"Sex Transm Dis"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/sextrans-2011-050385","article-title":"Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy","volume":"88","author":"PJ Horner","year":"2012","journal-title":"Sex Transm Dis"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2217\/fmb.10.96","article-title":"Antibiotic resistance in Chlamydiae","volume":"5","author":"KM Sandoz","year":"2010","journal-title":"Future Microbiol"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/428290","article-title":"Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: A meeting report","volume":"191","author":"SA Wang","year":"2005","journal-title":"J Infect Dis"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/648734","article-title":"Repeated Chlamydia trachomatis genital infections in adolescent women","volume":"201","author":"BE Batteiger","year":"2010","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa041681","article-title":"Effect of expedited treatment of sex partners on recurrent or persistent gonorrhoea or chlamydial infection","volume":"352","author":"MR Golden","year":"2005","journal-title":"NEJM"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cid\/ciu220","article-title":"Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials","volume":"59","author":"FY Kong","year":"2014","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jac\/31.suppl_E.39","article-title":"Selection of dose regimens of azithromycin","volume":"31","author":"G Foulds","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"ref19","first-page":"244","article-title":"Azithromycin levels in cervical mucus and plasma after a single 1.0g oral dose for chlamydial cervicitis","volume":"71","author":"AM Worm","year":"1995","journal-title":"Gen Med"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jpba.2006.05.011","article-title":"Quantitative determination of azithromycin in human plasma by liquid chromatography-mass spectrometry and its application in a bioequivalence study","volume":"42","author":"BM Chen","year":"2006","journal-title":"Journal of pharmaceutical and biomedical analysis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aca.2005.08.007","article-title":"Sensitive and selective liquid chromatography-tandem mass spectrometry method for the quantification of azithromycin in human plasma","volume":"553","author":"RVS Nirogi","year":"2005","journal-title":"Analytica Chimica Acta"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1365\/s10337-007-0294-7","article-title":"Analysis of Azithromycin in Human Plasma by LC-MS-MS","volume":"66","author":"N Yuzuak","year":"2007","journal-title":"Chromatographia"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/mas.10061","article-title":"Electrospray mass spectrometry of phospholipids","volume":"22","author":"M Pulfer","year":"2003","journal-title":"Mass Spectrom Rev"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jpba.2009.12.001","article-title":"Rapid, sensitive and selective liquid chromatography-tandem mass spectrometry (LC-MS\/MS) method for the quantification of topically applied azithromycin in rabbit conjunctiva tissues","volume":"52","author":"Y Shen","year":"2010","journal-title":"Journal of pharmaceutical and biomedical analysis"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2105\/AJPH.94.3.361","article-title":"Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement","volume":"94","author":"DC Des Jarlais","year":"2004","journal-title":"Am J Public Health"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.femsre.2005.03.002","article-title":"The chlamydial developmental cycle","volume":"29","author":"YM Abdelrahman","year":"2005","journal-title":"FEMS Microbiol Rev"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12879-015-1030-9","article-title":"Treatment challenges for urogenital and anorectal Chlamydia trachomatis","volume":"15","author":"FY Kong","year":"2015","journal-title":"BMC infectious diseases"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1128\/AAC.43.9.2268","article-title":"In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model","volume":"43","author":"A Kutlin","year":"1999","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1128\/AAC.02097-13","article-title":"Induction of the Chlamydia muridarum stress\/persistence response increases azithromycin treatment failure in a murine model of infection","volume":"58","author":"R Phillips-Campbell","year":"2014","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fcimb.2014.00044","article-title":"Commonly prescribed beta-lactam antibiotics induce C. trachomatis persistence\/stress in culture at physiologically relevant concentrations","volume":"4","author":"J Kintner","year":"2014","journal-title":"Front Cell Infect Microbiol"},{"issue":"Suppl 2","key":"ref31","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1086\/652394","article-title":"Chlamydia trachomatis persistence in vitro: an overview","volume":"201","author":"PB Wyrick","year":"2010","journal-title":"J Infect Dis"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1128\/IAI.72.4.1843-1855.2004","article-title":"Chlamydial persistence: beyond the biphasic paradigm","volume":"72","author":"RJ Hogan","year":"2004","journal-title":"Infect Immun"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10517-007-0221-9","article-title":"Analysis of antibiotic resistance markers in Chlamydia trachomatis clinical isolates obtained after ineffective antibiotic therapy","volume":"143","author":"MM Shkarupeta","year":"2007","journal-title":"Bull Exp Biol Med"},{"issue":"5","key":"ref34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000314998","article-title":"Decreased Susceptibility to Azithromycin and Doxycycline in Clinical Isolates of Chlamydia trachomatis Obtained from Recurrently Infected Female Patients in India","volume":"56","author":"AR Bhengraj","year":"2010","journal-title":"Chemotherapy"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1086\/315372","article-title":"Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure","volume":"181","author":"J Somani","year":"2000","journal-title":"J Infect Dis"},{"issue":"5","key":"ref36","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1128\/AAC.18.5.696","article-title":"Relative resistance to erythromycin in Chlamydia trachomatis","volume":"18","author":"A Mourad","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00007435-199808000-00005","article-title":"Comparative in vitro susceptibility of a tetracycline-resistant Chlamydia trachomatis strain isolated in Toulouse (France)","volume":"25","author":"JC Lefevre","year":"1998","journal-title":"Sexually Transmitted Diseases"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/infdis\/162.6.1309","article-title":"Partial characterization of chlamydia trachomatis isolates resistant to multiple antibiotics","volume":"162","author":"RB Jones","year":"1990","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1128\/AAC.48.4.1347-1349.2004","article-title":"Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides","volume":"48","author":"OY Misyurina","year":"2004","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1439-0272.2009.01019.x","article-title":"Mutations in 23S rRNA and ribosomal protein L4 account for resistance in Chlamydia trachomatis strains selected in vitro by macrolide passage","volume":"42","author":"H Zhu","year":"2010","journal-title":"Andrologia"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00007435-200106000-00003","article-title":"Self-collection of vaginal swabs for the detection of Chlamydia, gonorrhea, and trichomoniasis: opportunity to encourage sexually transmitted disease testing among adolescents","volume":"28","author":"HC Wiesenfeld","year":"2001","journal-title":"Sexually Transmitted Diseases"},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1902\/jop.1999.70.9.960","article-title":"Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases","volume":"70","author":"C Blandizzi","year":"1999","journal-title":"J Periodontol"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jac\/26.4.533","article-title":"The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin","volume":"26","author":"MA Cooper","year":"1990","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00044011-199815020-00009","article-title":"Pharmacokinetics of Oral Azithromycin in Serum, Urine, Polymorphonuclear Leucocytes and Inflammatory vs Non-Inflammatory Skin Blisters in Healthy Volunteers","volume":"15","author":"CH Ballow","year":"1998","journal-title":"Clin Drug Investig"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1128\/AAC.47.2.636-642.2003","article-title":"Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp","volume":"47","author":"RJ Suchland","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jac\/dkm476","article-title":"Tissue concentrations: do we ever learn?","volume":"61","author":"JW Mouton","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00044011-199816020-00009","article-title":"A Phase I Determination of Azithromycin in Plasma during a 6-Week Period in Normal Volunteers after a Standard Dose of 500mg Once Daily for 3 Days","volume":"16","author":"F Crokaert","year":"1998","journal-title":"Clin Drug Investig"},{"issue":"10","key":"ref48","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/BF01975843","article-title":"Azithromycin levels in plasma and gastric tissue, juice and mucus","volume":"10","author":"JD Harrison","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 3","key":"ref49","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1086\/321854","article-title":"Does the dose matter?","volume":"33","author":"WA Craig","year":"2001","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00001432-200104000-00010","article-title":"Pharmacokinetic and pharmacodynamic properties of antimicrobials in the therapy of respiratory tract infections","volume":"14","author":"D Andes","year":"2001","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"ref51","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1128\/AAC.02011-12","article-title":"Blood, tissue, and intracellular concentrations of azithromycin during and after end of therapy","volume":"57","author":"P Matzneller","year":"2013","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0177615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T11:13:33Z","timestamp":1569323613000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0177615"}},"subtitle":[],"editor":[{"given":"Giuseppe Vittorio","family":"De Socio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,12]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0177615","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,12]]}}}